ClinicalTrials.Veeva

Menu

The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction (OWL-HFPEF)

University of Oxford logo

University of Oxford

Status

Enrolling

Conditions

Heart Failure With Preserved Ejection Fraction
Obesity

Treatments

Other: Diet intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05878912
161729 (C)
15/SC/0004 (Other Identifier)
FS/CRTF/22/24293 (Other Grant/Funding Number)

Details and patient eligibility

About

This study looks at the effects of weight loss in people who have heart failure with preserved ejection fraction (HFpEF) and are overweight or obese.

The main questions it aims to answer are whether weight loss in this group of people improves:

  1. The heart's shape, how well it pumps blood and how well it uses fuels
  2. The person's quality of life and how much they can exercise

Participants will attend 2 study visits, separated by 3-6 months. The intervention period takes place in between the 2 study visits.

Each study visit will involve measurements including:

  • Symptom and quality of life questionnaires
  • Body measurements such as height and weight
  • Blood tests
  • Ultrasound scans of the heart (echocardiogram)
  • Magnetic Resonance Imaging (MRI) scans of the heart
  • Exercise components during the scans
  • 6 minute walk test

Participants are randomly allocated (in other words, by lottery) to either 'diet' or 'control' groups. The control group will continue standard care.

The diet group will be enrolled in a weight loss program supervised by the study team. Participants in the diet group will replace their usual meals with meal replacement products specifically designed to deliver a low calorie diet for weight loss. The products will consist of formula soups, shakes and porridges. This diet would last 8 weeks, followed by a guided period of food reintroduction and maintenance.

Full description

An interim analysis is planned at 60 recruits to review the recruitment target.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Heart failure with preserved ejection fraction (HFpEF)
  • Left ventricular ejection fraction (LVEF) =/> 50%
  • Body Mass Index (BMI) approximately =/> 27.5 kg/m^2

Exclusion criteria

  • Contraindications to magnetic resonance imaging
  • NYHA class IV
  • Significant valvular, ischemic, infiltrative or other potentially confounding cardiac disease
  • Pregnancy, planned pregnancy or lactating
  • Any other conditions which may potentially compromise the safety or scientific validity of the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups

Diet
Experimental group
Description:
Diet intervention (in addition to standard clinical care)
Treatment:
Other: Diet intervention
Control
No Intervention group
Description:
Standard clinical care only

Trial contacts and locations

1

Loading...

Central trial contact

Jiliu Pan, BMBCh; Jenny Rayner, DPhil

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems